OC
Ocugen
OCGN · NASDAQ
$1.35 +0.00% (+$0.00)
1M +3.13%
Market Cap $457.8M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.95
29.6% downside
Trenutna cena
$1.35
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica OCGN trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 99.96x
EV/EBITDA N/A
P/B N/A
Growth
100 /100
Growing Rev. growth 21.05%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 1,786.27%
Op. margin 1,504.43%
FCF margin 1,340.13%
Quality
1 /100
Poor ROA 65.87%
Asset turnover 0.04x
ROIC 92.68%
Debt
11 /100
High Int. coverage -8.63x
Current ratio 0.80x
Net debt/EBITDA N/A
Stability
23 /100
Unstable Rev. volatility 91.66%
EPS volatility 26.12%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o OCGN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Shankar Musunuri
Employees
116
Headquarters
Malvern
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report